Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 3 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

AGEN News and Commentary

Caps

How do you think AGEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

204 Outperform
83 Underperform
 

All-Star Players

37 Outperform
32 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top AGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.78)
Submitted April 03, 2013

I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to… More

SmartAce (99.93)
Submitted April 11, 2017

The easiest way to see the various stages of life is to walk down the cereal aisle at the grocery store.

AGEN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about AGEN.

Recs

0
Member Avatar HDTVBG (< 20) Submitted: 6/21/2017 2:00:46 AM : Outperform Start Price: $3.89 AGEN Score: +3.84

Looks like hedge funds have rotated into Biotech. Risk on.

Recs

1
Member Avatar SmartAce (99.93) Submitted: 4/11/2017 3:04:18 PM : Underperform Start Price: $3.21 AGEN Score: -21.99

The easiest way to see the various stages of life is to walk down the cereal aisle at the grocery store.

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/2/2017 3:52:31 PM : Outperform Start Price: $4.16 AGEN Score: -4.86

Tries to harness immunity to fight disease. In other words: another hopeful biotech. Or maybe it's just me who's hopeful.

Leaderboard

Find the members with the highest scoring picks in AGEN.

Score Leader

epc53

epc53 (28.18) Score: +238.15

The Score Leader is the player with the highest score across all their picks in AGEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.60 6/8/2009 Underperform 3W $13.68 -70.54% +161.47% +232.02 0 Comment
svande8952 < 20 6/16/2009 Underperform 5Y $12.24 -67.08% +164.76% +231.84 1 Comment
TWreckz 99.13 6/5/2009 Underperform 5Y $15.90 -74.65% +156.89% +231.55 0 Comment
rcbaldwinjr 62.39 8/5/2009 Underperform 3W $13.85 -70.91% +144.64% +215.55 0 Comment
rhinomaj 93.53 8/4/2009 Underperform 3M $14.34 -71.90% +143.10% +215.00 0 Comment
epc53 28.18 8/7/2009 Underperform 5Y $13.26 -69.61% +141.73% +211.33 0 Comment
chop3399 < 20 3/13/2008 Underperform 5Y $13.44 -70.01% +95.27% +165.28 0 Comment
ortiz176 60.16 4/14/2008 Underperform 1Y $15.48 -73.97% +89.95% +163.92 0 Comment
slade15342 95.90 4/9/2008 Underperform 3M $17.28 -76.68% +85.01% +161.69 0 Comment
JackOffBadApples 88.84 9/12/2008 Underperform 3W $10.02 -59.78% +101.55% +161.33 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.49 1/9/2015 Outperform 3W $5.29 -23.82% +18.89% -42.71 0 Comment
TrackWMBlair 79.90 1/5/2012 Outperform NS $2.12 +90.09% +89.84% +0.26 0 Comment
trackglobalhunte < 20 12/1/2011 Outperform NS $2.44 +65.16% +94.51% -29.34 0 Comment
trackmlvcapital < 20 9/13/2011 Outperform NS $3.42 +17.84% +107.47% -89.63 0 Comment
TrackDawsonJames < 20 6/1/2011 Outperform NS $5.58 -27.78% +80.54% -108.31 0 Comment
TrackRodmanRen < 20 5/9/2011 Outperform NS $5.75 -29.95% +79.97% -109.92 0 Comment

Featured Broker Partners